| Primary |
| Asthma |
32.5% |
| Status Asthmaticus |
20.1% |
| Chronic Obstructive Pulmonary Disease |
11.4% |
| Bronchospasm |
5.0% |
| Rhinorrhoea |
5.0% |
| Dyspnoea |
4.1% |
| Respiratory Failure |
2.6% |
| Respiratory Distress |
2.2% |
| Hypertension |
2.0% |
| Bronchial Hyperreactivity |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Cough |
1.5% |
| Anxiety |
1.3% |
| Bronchiolitis |
1.3% |
| Emphysema |
1.3% |
| Pneumonia |
1.3% |
| Respiratory Therapy |
1.3% |
| Supplementation Therapy |
1.3% |
| Cardiac Disorder |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
|
| Drug Ineffective |
25.8% |
| Pupils Unequal |
12.9% |
| Product Quality Issue |
9.1% |
| Dyspnoea |
6.8% |
| Drug Effect Decreased |
3.8% |
| Hemiparesis |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Cough |
3.0% |
| Epistaxis |
3.0% |
| Eye Pain |
3.0% |
| Headache |
3.0% |
| Pharmaceutical Product Complaint |
3.0% |
| Product Substitution Issue |
3.0% |
| Tachycardia |
3.0% |
| Anaphylactic Reaction |
2.3% |
| Hyperglycaemia |
2.3% |
| Medication Error |
2.3% |
| Mydriasis |
2.3% |
| Sensory Disturbance |
2.3% |
| Transient Ischaemic Attack |
2.3% |
|
| Secondary |
| Asthma |
29.5% |
| Chronic Obstructive Pulmonary Disease |
16.5% |
| Product Used For Unknown Indication |
14.4% |
| Drug Use For Unknown Indication |
9.5% |
| Hypertension |
4.2% |
| Dyspnoea |
2.8% |
| Bronchitis |
2.7% |
| Respiratory Distress |
2.2% |
| Diabetes Mellitus |
1.9% |
| Pyrexia |
1.8% |
| Back Pain |
1.7% |
| Breast Cancer |
1.7% |
| Pulmonary Tuberculosis |
1.7% |
| Arthralgia |
1.4% |
| Bronchitis Chronic |
1.4% |
| Condition Aggravated |
1.4% |
| Drug Exposure During Pregnancy |
1.4% |
| Cough |
1.3% |
| Depression |
1.3% |
| Cardiac Disorder |
1.1% |
|
| Transient Ischaemic Attack |
9.9% |
| Drug Ineffective |
6.9% |
| Wheezing |
6.9% |
| Dyspnoea |
6.1% |
| Feeling Abnormal |
6.1% |
| Respiratory Failure |
6.1% |
| Vomiting |
6.1% |
| Metabolic Alkalosis |
5.3% |
| Status Asthmaticus |
5.3% |
| Tremor |
5.3% |
| Neutropenia |
4.6% |
| Medication Error |
3.8% |
| Pneumonia |
3.8% |
| Somnolence |
3.8% |
| Tachypnoea |
3.8% |
| Urinary Retention |
3.8% |
| Exposure During Pregnancy |
3.1% |
| Heart Rate Increased |
3.1% |
| Hepatitis Fulminant |
3.1% |
| Nausea |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.8% |
| Drug Use For Unknown Indication |
21.3% |
| Chronic Obstructive Pulmonary Disease |
7.7% |
| Asthma |
6.5% |
| Pain |
3.8% |
| Prophylaxis |
3.4% |
| Hypertension |
3.1% |
| Rheumatoid Arthritis |
1.6% |
| Multiple Myeloma |
1.6% |
| Depression |
1.5% |
| Dyspnoea |
1.4% |
| Emphysema |
1.4% |
| Diabetes Mellitus |
1.4% |
| Pneumonia |
1.4% |
| Osteoporosis |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Constipation |
1.3% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Atrial Fibrillation |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Vomiting |
12.8% |
| Pneumonia |
10.1% |
| Wheezing |
8.2% |
| Death |
6.3% |
| Dyspnoea |
6.3% |
| Respiratory Failure |
5.3% |
| Drug Ineffective |
4.8% |
| Weight Decreased |
4.7% |
| Sepsis |
4.1% |
| Vision Blurred |
4.1% |
| Nausea |
3.9% |
| Weight Increased |
3.9% |
| Thrombocytopenia |
3.8% |
| Renal Failure Acute |
3.7% |
| Renal Failure |
3.4% |
| Asthma |
3.2% |
| Tachycardia |
3.0% |
| Pyrexia |
2.9% |
| Pulmonary Embolism |
2.8% |
| Rash |
2.8% |
|
| Interacting |
| Dyspnoea |
55.6% |
| Arthralgia |
11.1% |
| Ex-tobacco User |
11.1% |
| Gastric Disorder |
11.1% |
| Nerve Degeneration |
11.1% |
|
| Abasia |
50.0% |
| Vision Blurred |
50.0% |
|
